Ulcerated infantile haemangiomas: the effect of the selective beta-blocker atenolol on wound healing
G. Ruitenberg
Department of Pediatric Plastic Surgery, Wilhelmina Children's Hospital, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, the Netherlands
Search for more papers by this authorD.A. Young-Afat
Department of Clinical Epidemiology, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands
Search for more papers by this authorM. de Graaf
Department of Pediatric Dermatology and Allergology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, the Netherlands
Search for more papers by this authorS.G.M.A. Pasmans
Department of Pediatric Dermatology and Allergology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, the Netherlands
Department of Pediatric Dermatology, Erasmus University Medical Centre Rotterdam, Sophia's Children Hospital, Rotterdam, the Netherlands
Search for more papers by this authorC.C. Breugem
Department of Pediatric Plastic Surgery, Wilhelmina Children's Hospital, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, the Netherlands
Search for more papers by this authorG. Ruitenberg
Department of Pediatric Plastic Surgery, Wilhelmina Children's Hospital, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, the Netherlands
Search for more papers by this authorD.A. Young-Afat
Department of Clinical Epidemiology, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands
Search for more papers by this authorM. de Graaf
Department of Pediatric Dermatology and Allergology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, the Netherlands
Search for more papers by this authorS.G.M.A. Pasmans
Department of Pediatric Dermatology and Allergology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, the Netherlands
Department of Pediatric Dermatology, Erasmus University Medical Centre Rotterdam, Sophia's Children Hospital, Rotterdam, the Netherlands
Search for more papers by this authorC.C. Breugem
Department of Pediatric Plastic Surgery, Wilhelmina Children's Hospital, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, the Netherlands
Search for more papers by this author
References
- 1Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 2015; 372: 735–46.
- 2de Graaf M, Raphael MF, Breugem CC et al. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group. J Plast Reconstr Aesthet Surg 2013; 66: 1732–40.
- 3Raphaël MF, de Graaf M, Breugem CC et al. Atenolol: a promising alternative to propranolol for the treatment of hemangiomas. J Am Acad Dermatol 2011; 65: 420–1.
- 4Abarzúa-Araya A, Navarrete-Dechent CP, Heusser F et al. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study. J Am Acad Dermatol 2014; 70: 1045–9.
- 5Hermans DJ, van Beynum IM, Schultze Kool LJ et al. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. J Am Acad Dermatol 2011; 64: 833–8.
- 6Saint-Jean M, Léauté-Labrèze C, Mazereeuw-Hautier J et al. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol 2011; 64: 827–32.
- 7Sharma VK, Fraulin FO, Dumestre DO et al. Beta blockers for the treatment of problematic hemangiomas. Can J Plast Surg 2013; 21: 23–8.
- 8Janmohamed SR, de Waard-van der Spek FB, Madern GC et al. Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS). Clin Exp Dermatol 2011; 36: 715–23.
- 9Ma G, Wu P, Lin X et al. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study. Pediatr Dermatol 2014; 31: 286–91.
- 10Qiu Y, Ma G, Yang J et al. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study. Clin Exp Dermatol 2013; 38: 845–50.
- 11Nieuwenhuis K, de Laat PC, Janmohamed SR et al. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol. Pediatr Dermatol 2013; 30: 64–70.
- 12Janmohamed SR, Madern GC, Nieuwenhuis K et al. Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol. Pediatr Surg Int 2012; 28: 393–8.
- 13Kim HJ, Colombo M, Frieden IJ. Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol 2001; 44: 962–72.
- 14Pandey A, Gangopadhyay AN, Sharma SP et al. Conservative management of ulcerated haemangioma – twenty years experience. Int Wound J 2009; 6: 59–62.
- 15Hermans DJ, Boezeman JB, Van de Kerkhof PC et al. Differences between ulcerated and non-ulcerated hemangiomas, a retrospective study of 465 cases. Eur J Dermatol 2009; 19: 152–6.
